Elegant Health Acquires Israeli Digital Health Startup Laguna Health
US-based Elligint Health has acquired Israeli digital health startup Laguna Health for tens of millions of dollars. Laguna's conversational AI platform will be integrated into Elligint's care management systems, while its Tel Aviv hub is set for expansion.
The US-based healthcare management company Elligint Health has acquired the Israeli digital health startup Laguna Health for an estimated tens of millions of dollars. Founded in 2020 by Yoni Stein and Yael Peled-Adam, Laguna operates out of Tel Aviv and employs approximately 20 people. Since its inception, the company has raised around $30 million from prominent investors, including Pitango, LionBird, Arkin Holdings, HC9, SemperVirens, and private backers.
Laguna has developed a conversational artificial intelligence platform designed for healthcare case managers at insurance companies. Traditionally, case managers spend a significant portion of their working hours documenting patient conversations rather than engaging directly with them. Laguna's system utilizes AI to automatically document calls, perform quality assurance, generate real-time insights, and evaluate compliance with clinical and operational standards.
Following the acquisition, Laguna will operate as a wholly owned subsidiary of Elligint Health and will serve as its core AI development hub in Israel. Elligint Health plans to invest heavily in the local operation, aiming to double its workforce by hiring key technical roles, including software developers and AI engineers, alongside sales professionals targeting the US market. Yoni Stein will continue to lead Laguna and its operations in Israel.
Elligint Health provides care management and utilization management systems, as well as analytics tools, to major US health insurance companies, managing healthcare for over 13 million members. Laguna's products will be fully integrated into Elligint Health's broader suite of offerings.
"We are embarking on an exciting new chapter that will support our vision to improve healthcare services for millions of patients worldwide," said Yoni Stein, co-founder and CEO of Laguna Health. "Thanks to Elligint Health's extensive reach among health insurers, we will be able to bring our technology to many more care teams, all from our development center in Israel."
Chris Carmanico, CEO of Elligint Health, highlighted the strategic importance of the acquisition: "We are thrilled to acquire Laguna, founded by two exceptional entrepreneurs, and to establish our presence in Israel, a recognized hub of technological innovation. Laguna's conversational AI solutions align perfectly with our value proposition, and we intend to expand the Tel Aviv development center to further support platform growth."
